Retatrutide (30mg)

Overview

Retatrutide is an investigational triple-receptor agonist peptide targeting GLP-1, GIP, and glucagon receptors. It is studied in laboratory settings for its role in receptor signaling and metabolic pathway research.

Specifications

• Contents: 30mg per vial
• Form: Lyophilized powder, sealed vial
• Purity: Third-party tested; see the batch Certificate of Analysis (COA)
• Storage: Store sealed, protected from light; refrigerate or freeze for long-term storage

Quality & Testing

Every batch ships with lot traceability. Certificates of Analysis are available on request or via the COA history for this product.

For Research Use Only. Not for human or veterinary use. Not approved by the FDA and not intended to diagnose, treat, cure, or prevent any disease. Sold only to qualified researchers for in-vitro and laboratory study.